Aurinia Pharmaceuticals Inc (AUPH)

[Churchill54]

The markets were long overdue for a correction and looking for any excuse to sell off. Auph was taken down disproportionately by the professional manipulators who very much want cheap shares. Additionally some retailers were disappointed by the apparent willingness by the company to go it alone if necessary which likely exacerbated the downturn for Auph. However, despite a possible bear market and even if a buyer isn’t forthcoming, Auph will thrive in the months ahead as it becomes increasingly more obvious that the company is very undervalued relative to the potential revenue which will be realized from the LN indication alone. The corona virus fears will abate eventually although the markets may take time to recover from the economic fallout . The better companies like Auph will continue to do well despite the incipient bear market and I believe that the company will be sold within the next year although making preparations to go it alone if necessary.